|
Variables
|
Total Cohort (n = 100)
|
p Value
|
|---|
|
Control Group (n = 30)
|
Non-responder Group (n = 32)
|
Responder Group (n = 38)
|
|---|
|
Age, yrs
|
46 ± 1
|
62 ± 2
|
62.35 ± 1.67
|
< 0.0001
|
|
Female/Male
|
12/18(1:1.5)
|
8/24(1:3)
|
13/25(1:1.9)
|
0.01
|
|
NYHA functional class
|
/
|
3.03 ± 0.67
|
2.85 ± 0.46
|
0.17
|
|
QRS, ms
|
81 ± 2.52
|
149 ± 6.37
|
151 ± 5.26
|
< 0.0001
|
|
Ischemic etiology
|
/
|
4(12%)
|
4(10%)
|
0.64
|
|
LVEF, %
|
69.45 ± 0.73
|
26.50 ± 1.91
|
26.45 ± 1.05
|
< 0.0001
|
|
LVEDV, ml
|
62.50 ± 1.93
|
282.30 ± 21.56
|
203.00 ± 11.30***
|
< 0.0001
|
|
LVESV, ml
|
18.80 ± 0.61
|
210.40 ± 20.14
|
150.20 ± 9.29**
|
< 0.0001
|
|
TTO-16-SD, %
|
2.85 ± 0.23
|
9.65 ± 0.85
|
14.04 ± 2.01*
|
< 0.0001
|
|
TTP-16-SD, %
|
3.73 ± 0.18
|
12.45 ± 1.12
|
16.83 ± 2.90
|
< 0.0001
|
- LVEF Left Ventricle Eject Fraction, LVEDV Left ventricle end diastolic volume, LVESV Left ventricle end systolic volume, TTO-16-SD 16-segement Standard deviation of time to onset strain, TTP-16-SD 16-segement Standard deviation of time to peak strain
- Compared Responder Group to Non-responder Group: *p < 0.05; **p < 0.01; ***p < 0.001
